We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
+12.33%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.32B
AUM Growth
-$166M
(-11%)
Cap. Flow
-$302M
Cap. Flow
% of AUM
-22.85%
Top 10 Holdings %
Top 10 Hldgs %
73.44%
Holding
28
New
3
Increased
5
Reduced
7
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Community Health Systems
CYH
|
+$75.2M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$41.9M |
| 3 |
Baxter International
BAX
|
+$34.9M |
| 4 |
KND
Kindred Healthcare
KND
|
+$10.4M |
| 5 |
AFAM
Almost Family Inc
AFAM
|
+$5.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$87.2M |
| 2 |
Quest Diagnostics
DGX
|
+$67.1M |
| 3 |
Bausch Health
BHC
|
+$44.3M |
| 4 |
WW
WW International
WW
|
+$42.2M |
| 5 |
GTIV
GENTIVA HEALTH SERVICES INC
GTIV
|
+$38.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 82.51% |
| 2 | Consumer Discretionary | 4.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEM
1
DELISTED
Select Medical
SEM
| $199M | 15.09% |
24,963,200
-928,000
| -4% | -$6.93M |
|
|
KND
2
DELISTED
Kindred Healthcare
KND
| $131M | 9.92% |
5,513,999
+513,999
| +10% | +$10.4M |
|
|
AMED
3
DELISTED
Amedisys
AMED
| $107M | 8.1% |
4,000,000
| – | – |
|
|
4
Teva Pharmaceuticals
TEVA
$35.9B
| $93.5M | 7.07% |
1,500,000
-1,500,000
| -50% | -$87.2M |
|
|
SVU
5
DELISTED
SUPERVALU Inc.
SVU
| $81.4M | 6.16% |
1,000,000
+71,429
| +8% | +$5.12M |
|
6
Boston Scientific
BSX
$65.8B
| $79.9M | 6.04% |
4,500,000
-500,000
| -10% | -$7.9M |
|
|
7
Community Health Systems
CYH
$385M
| $78.4M | 5.93% |
+1,815,000
| New | +$75.2M |
|
|
TVTY
8
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $75.8M | 5.74% |
3,850,000
| – | – |
|
9
Orthofix Medical
OFIX
$455M
| $64.6M | 4.89% |
1,800,000
| – | – |
|
10
Viatris
VTRS
$20.1B
| $59.4M | 4.49% |
1,000,000
-500,000
| -33% | -$28.5M |
|
|
AFAM
11
DELISTED
Almost Family Inc
AFAM
| $55.9M | 4.23% |
1,250,000
+159,500
| +15% | +$5.34M |
|
|
12
Bausch Health
BHC
$1.65B
| $49.7M | 3.76% |
250,000
-250,000
| -50% | -$44.3M |
|
|
GHDX
13
DELISTED
Genomic Health, Inc.
GHDX
| $45.8M | 3.47% |
1,500,000
| – | – |
|
|
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
| $43.4M | 3.28% |
+500,000
| New | +$41.9M |
|
|
ELOS
15
DELISTED
Syneron Medical Ltd
ELOS
| $37.1M | 2.81% |
3,000,000
| – | – |
|
|
MGLN
16
DELISTED
Magellan Health Services, Inc.
MGLN
| $35.4M | 2.68% |
500,000
-200,000
| -29% | -$12.6M |
|
|
17
Baxter International
BAX
$11.6B
| $34.3M | 2.59% |
+920,500
| New | +$34.9M |
|
|
VVUS
18
DELISTED
Vivus Inc
VVUS
| $30.8M | 2.33% |
1,250,000
+119,520
| +11% | +$3.32M |
|
|
FRED
19
DELISTED
Fred's Inc
FRED
| $10.9M | 0.83% |
638,900
-861,100
| -57% | -$15.4M |
|
|
AEGR
20
DELISTED
Aegerion Pharmaceuticals
AEGR
| $7.85M | 0.59% |
300,000
+100,000
| +50% | +$2.54M |
|
21
AbbVie
ABBV
$458B
| – | – |
-500,000
| Closed | -$32.7M |
|
22
Accuray
ARAY
$28.4M
| – | – |
-2,000,000
| Closed | -$15.1M |
|
|
23
Quest Diagnostics
DGX
$25.1B
| – | – |
-1,000,000
| Closed | -$67.1M |
|
24
Myriad Genetics
MYGN
$530M
| – | – |
-1,100,000
| Closed | -$37.5M |
|
|
WW
25
DELISTED
WW International
WW
| – | – |
-1,700,000
| Closed | -$42.2M |
|
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q1 2015 Portfolio in Review
As of Q1 2015, North Tide Capital held 28 positions worth $1.32B, down 11% from $1.49B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
North Tide Capital withdrew a net $302M in Q1 2015, closing 8 positions and reducing 7 holdings. Its most notable exit was Quest Diagnostics, an estimated $67.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 83% of assets, up from 80% a quarter earlier, followed by Consumer Discretionary.
Against the trend, North Tide Capital opened a new position in Community Health Systems worth $78.4M.
- North Tide Capital's largest Q1 2015 buy was Community Health Systems: 1,815,000 shares worth $78.4M.
- North Tide Capital added most to Kindred Healthcare in Q1 2015, an estimated $10.4M increase.
- North Tide Capital's biggest Q1 2015 reduction was Teva Pharmaceuticals, cutting an estimated $87.2M.
- North Tide Capital fully exited Quest Diagnostics in Q1 2015, selling an estimated $67.1M.
- North Tide Capital's ten largest holdings make up 73% of its $1.32B portfolio in Q1 2015.
- North Tide Capital opened 3 new positions and closed 8 in Q1 2015.
- North Tide Capital's portfolio value fell 11% quarter-over-quarter to $1.32B.
Based on North Tide Capital's 13F filing for Q1 2015, filed 15 May 2015.